{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:46:41Z","timestamp":1775083601676,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajoc.2023.101964","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T07:30:30Z","timestamp":1700897430000},"page":"101964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Topical fosaprepitant for the treatment of ocular pain and inflammation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-0584","authenticated-orcid":false,"given":"Giuseppe","family":"Suanno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Pederzolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina Mayra","family":"Lasagni Vitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajoc.2023.101964_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-020-00263-9","article-title":"Ocular surface pain: a NarrativeReview","volume":"9","author":"Mehra","year":"2020","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajoc.2023.101964_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.survophthal.2020.05.006","article-title":"Fibromyalgia syndrome and the eye-A review","volume":"66","author":"Zdebik","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2023.101964_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2019.07.001","article-title":"NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation","volume":"65","author":"Rigas","year":"2020","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2023.101964_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101964_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40135-017-0152-1","article-title":"Diagnosis and treatment of ocular pain: the ophthalmologist's perspective","volume":"5","author":"Jacobs","year":"2017","journal-title":"Curr Ophthalmol Rep"},{"issue":"Oct","key":"10.1016\/j.ajoc.2023.101964_bib6","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajoc.2023.101964_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100974","article-title":"The two-faced effects of nerves and neuropeptides in corneal diseases","volume":"86","author":"Lasagni Vitar","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.ajoc.2023.101964_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1167\/iovs.17-23198","article-title":"Substance P modulation of human and murine corneal neovascularization","volume":"59","author":"Barbariga","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2023.101964_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtos.2022.06.007","article-title":"Modulating the tachykinin: role of substance P and neurokinin receptor expression in ocular surface disorders","volume":"25","author":"Singh","year":"2022","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajoc.2023.101964_bib10","article-title":"Modulating ocular surface pain through neurokinin-1 receptor blockade","volume":"62","author":"Vitar","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajoc.2023.101964_bib11","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1111\/aos.13304","article-title":"Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment","volume":"95","author":"Bignami","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101964_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1634\/theoncologist.2014-0229","article-title":"Aprepitant and fosaprepitant: a 10-year review of efficacy and safety","volume":"20","author":"Aapro","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2023.101964_bib13","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/ICO.0000000000002116","article-title":"Pain, dryness, and itch sensations in eye surface disorders are defined by a balance between inflammation and sensory nerve injury","volume":"38","author":"Belmonte","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2023.101964_bib14","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajoc.2023.101964_bib15","article-title":"Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model","volume":"212","author":"Vitar","year":"2021","journal-title":"Exp Eye Res"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362300172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362300172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:04:40Z","timestamp":1762527880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199362300172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":15,"alternative-id":["S245199362300172X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101964","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical fosaprepitant for the treatment of ocular pain and inflammation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101964"}}